Stock Offerings
Celcuity appears to be next in line for IPO
Celcuity, a Plymouth-based biotechnology company, last week filed an amended registration statement for an initial public offering (IPO) of stock.
The Nasdaq website indicates on its IPO calendar that Celcuity could price its offering this week.
Celcuity would be the third Minnesota-based company to complete an IPO this year.
Celcuity is developing a medical diagnostic test that uses a patient's live tumor cells to provide "the most biologically complete diagnosis available."
A better diagnosis can lead to better drug choices and improved cancer treatment outcomes for patients.
The company looks to raise $23 million from the IPO by selling 2 million shares in an offering range of $8 to $10 per share. An additional 300,000 shares are available in an overallotment.
The last time more than two Minnesota companies completed IPOs in the same year was in 2007.
Earlier this year ASV Holdings Inc., a maker of compact track loaders and skid steer loaders based in Grand Rapids, and Calyxt, a gene-editing company in New Brighton, completed sales of stock to the public.